Latest News about SNY
Recent news which mentions SNY
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
From Benzinga
7 Blue-Chip Stocks to Buy for Quality-Focused Investors
March 06, 2023
From InvestorPlace
From Motley Fool
Eli Lilly CEO says $35 for monthly insulin ‘should be the new standard in America’ — and experts say that could happen
March 01, 2023
From MarketWatch
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
March 01, 2023
From Benzinga
From Benzinga
This chart gives one reason European stocks may continue to outperform U.S. equities
February 17, 2023
From MarketWatch
BioRestorative (NASDAQ: BRTX) Ramps Up Production In Anticipation Of Positive Phase 2 Results
February 03, 2023
From Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
From Benzinga
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics Competition
February 03, 2023
Tickers
SNY
From Benzinga
Alphabet, Apple And 3 Stocks To Watch Heading Into Friday
February 03, 2023
From Benzinga
Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Sharp Gains For Fourth Straight Week
February 03, 2023
From Benzinga
Tickers
SNY
From MarketWatch
From Benzinga
Sanofi Layoffs 2023: What to Know About the Latest SNY Job Cuts
January 31, 2023
Tickers
SNY
From InvestorPlace
Sanofi Might Pull Down Shutters For Two Vaccine Plants In India
January 30, 2023
Tickers
SNY
From Benzinga
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis
January 30, 2023
From Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
Could This Vaccine Become Sanofi's Latest Blockbuster?
January 29, 2023
From Motley Fool
7 Blue-Chip Stocks to Buy as a New Bull Market Emerges
January 26, 2023
From InvestorPlace
Wall Street Thinks These 2 Blazing Healthcare Stocks Could Have 21% to 30% Upside in 2023
January 23, 2023
From Motley Fool
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
From Benzinga
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
From Benzinga
What This Drug News Could Mean for Sanofi Shareholders
January 08, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.